Clinical Trial Update: Pharmacokinetics Study of Liposomal Paclitaxel in Humans [Phase 4]

View source ↗

Summary

Phase 4 pharmacokinetics study of liposomal paclitaxel in humans has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• liposomal paclitaxel (liposomal paclitaxel)

Snippet

Sponsor: Shandong Luye Pharmaceutical Co., Ltd. | Conditions: Cancer | Phase 4 | Status: COMPLETED